| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |